Related Experiment Video
Updated: May 22, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Cytokine/chemokine patterns connect host and viral characteristics with clinics during chronic hepatitis C
Antonios Katsounas1, Martin Trippler, Shyam Kottilil
1Department of Gastroenterology and Hepatology, University Hospital of Essen, Germany. antonios.katsounas@uk-essen.de
Insights
This study identifies key immune response genes, TNFRSF1A and CCR5, associated with hepatitis C virus (HCV) treatment outcomes and disease progression. These findings highlight potential molecular targets for improving patient response to therapy.
Area of Science:
- Immunology
- Hepatology
- Genomics
Background:
- Chronic hepatitis C virus (HCV) infection involves complex virus-host interactions impacting clinical outcomes.
- Liver pathology and HCV genotype are critical determinants of treatment success.
- Understanding in vivo transcriptional responses in HCV is crucial but incomplete.
Purpose of the Study:
- To investigate in vivo transcriptional responses in peripheral blood of HCV patients.
- To identify gene expression profiles correlating with treatment response, viral factors, and liver disease severity.
- To uncover molecular pathways and targets involved in HCV infection and treatment.
Main Methods:
- Microarray analysis of peripheral whole blood samples from 36 therapy-naïve HCV patients.
- Linear regression to identify gene expression correlations with 7 clinical variables (SVR, NR, ETR, VB, genotype, fibrosis, inflammation).
- Hierarchical clustering and functional annotation (DAVID) to analyze gene expression patterns.
Main Results:
- 1,697 genes showed significant correlations; cell differentiation, immune response, and apoptosis were prominent.
- Expression profiles were enriched in cytokine/chemokine activity.
- Four immune genes (SMAD3, IL1RAP, TNFRSF1A, CCR5) were identified, with TNFRSF1A and CCR5 correlating with multiple variables.
Conclusions:
- Identified molecular targets within the innate and adaptive immune systems.
- Validated transcriptional specificity in vivo.
- Suggests significant involvement of TNFRSF1A and CCR5 in distinct HCV treatment outcomes.
Background:
In chronic hepatitis C virus (HCV) infection, liver tissue pathology and HCV genotype are important determinants of clinical and/or treatment-related outcome. Although consistent epidemiological and/or molecular-biological clues derived from different studies on single virus-host interactions are meanwhile published, the in vivo transcriptional responses and cellular pathways affected in >1 key aspects of the disease or treatment process are far from being understood.
Methods:
Microarray analysis was performed in peripheral whole blood (PB) samples from 36 therapy-naïve HCV-infected patients with known liver histology. Linear regression analysis identified gene expression profiles significantly correlating (P < 0.015) with ≥1 out of 7 variables: sustained viral response (SVR), viral non-response (NR), end of treatment viral response (ETR), viral breakthrough (VB), HCV genotype (Gt. 1 vs. Gt. 2/3), stage of hepatic fibrosis [St. 0/1 vs. St. 2/3/4] and grade of hepatic inflammation (Gr. 0/1 vs. Gr. 2/3/4). Correlation values across all seven contrasts were considered for hierarchical clustering (HCL).
Results:
A total of 1,697 genes showed ≥1 significant correlation results and genes involved in cell differentiation (183), immune response (53), and apoptosis (170) were leading fractions. HCL grouped the genes into six major clusters. Functional annotation analysis using DAVID (http://david.abcc.ncifcrf.gov) revealed that expression profiles that best linked these variables were highly enriched in cytokine/chemokine activity (Fisher-exact P < 0.0001) and specific biological module-centric algorithms finally led our focus on four out of fifty-three immune response genes: SMAD family member 3 (SMAD3), interleukin 1 receptor accessory protein (IL1RAP), tumor necrosis factor receptor superfamily member 1A (TNFRSF1A), and chemokine 'C-C motif' receptor 5 (CCR5). Of those, TNFRSF1A and CCR5 showed significant correlation with two out of seven variables based on microarray and/or quantitative real-time polymerase chain reaction (qRT-PCR) data.
Conclusion:
We identified molecular targets of the innate and adaptive immune system and validated their transcriptional specificity in vivo suggesting significant involvement in two unique outcomes during HCV treatment.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytomegalovirus Disease
Inhibitors of Viral Protein Synthesis
Cirrhosis II: Pathophysiology

